OKLAHOMA CITY, Oct. 27 /PRNewswire/ -- TriMarc Laboratories announced today the availability of two new prescription medications to the pharmaceutical market. With its first launch, TriMarc will introduce Benzoyl Peroxide 5% and Benzoyl Peroxide 10%. The Benzoyl Peroxide base products will be available for distribution starting today.
Benzoyl Peroxide Gel is indicated for the topical treatment of mild to moderate acne vulgaris. Benzoyl Peroxide Gel may be used with other acne treatments including retinoic acid products, antibiotics and sulfur/salicylic acid containing preparations. The Benzoyl Peroxide will be made available in an Aqueous Base Gel formulation designed exclusively for TriMarc Labs.
ABOUT THE COMPANY
TriMarc Laboratories will offer exclusively licensed and patented pharmaceutical products to an ever-growing healthcare market. TriMarc Labs is contracted with research organization and selective manufacturers to design new innovative products for the pharmaceutical industry. TriMarc Labs will be focusing on key products and their marketplace, affording TriMarc the opportunity to gain a greater share of the healthcare industry with competitive products and prices. TriMarc Labs will be offering co-marketing and networking programs to selective manufacturers, distributors, and wholesalers.
This press release contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks and uncertainties or other factors, which may cause actual results, performance or achievements expressed or implied by such forward-looking statements to vary from those forecast or implied in this release. Factors that might cause such a difference include, without limitation, decline in demand for the company's products or services, and the effect of general economic conditions and factors affecting the industry.
CONTACT: TriMarc Laboratories, +1-405-942-3040, email@example.com